What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to officially provide the market with the press release that details Elevance Health's (then Anthem, Inc.) financial results for the third quarter ended September 30, 2018. It's a formal way to disseminate this important earnings information.

Does this filing contain detailed financial statements?

No, this 8-K filing does not contain detailed financial statements itself. Instead, it incorporates by reference Exhibit 99.1, which is the press release containing the financial results for the third quarter.

What are the most significant risks highlighted in the filing?

The filing extensively details numerous risks, but particularly emphasizes regulatory changes (like the ACA and Medicare/Medicaid programs), healthcare cost inflation, competitive market pressures, and significant ongoing litigation, notably the dispute with Cigna related to a past merger agreement. Other notable risks include data security breaches and operational challenges with key partnerships like Express Scripts.

ELV 8-K: Earnings & Results

Q: What is the significance of the information being 'furnished' versus 'filed'?

Information that is 'furnished' in an 8-K, such as the press release in this case, is generally not subject to the same legal liabilities under Section 18 of the Securities Exchange Act of 1934 that 'filed' information is. While it's made public, the company has less liability if statements within it are found to be inaccurate.

Summary

This 8-K filing by Elevance Health, Inc. (formerly Anthem, Inc.) on October 31, 2018, primarily serves to furnish a press release announcing the company's financial results for the third quarter ended September 30, 2018. Investors should note that this information is furnished and not formally filed, meaning it is not subject to the same liabilities under Section 18 of the Securities Exchange Act of 1934. The filing doesn't provide detailed financial statements within the 8-K itself but directs readers to the attached press release for the specific results. Crucially, the filing includes extensive "forward-looking statements" outlining various risks and uncertainties that could impact future performance. These cover a broad range of factors including regulatory changes (ACA, Medicare/Medicaid), healthcare cost trends, provider contracting, premium rate approvals, enrollment changes, CMS Star ratings, competitive pressures, product mix, litigation (notably with Cigna regarding a past merger agreement), medical malpractice claims, dividend restrictions, indebtedness, financial strength ratings, data breaches, information systems, pharmacy benefit management agreements (Express Scripts), state guaranty fund assessments, Blue Cross Blue Shield licenses, business concentrations, public health events, M&A risks, share repurchases, intangible asset impairment, economic and market conditions, tax law changes, employee retention, anti-takeover provisions, and general economic downturns. Investors should carefully consider these disclosed risks when evaluating the company's future prospects.

Key Highlights

1Furnishes press release detailing Q3 2018 financial results for Elevance Health (then Anthem, Inc.).
2Press release dated October 31, 2018, reports on the quarter ended September 30, 2018.
3Information furnished is not deemed 'filed' under Section 18 of the Securities Exchange Act of 1934.
4Extensive list of forward-looking statements and associated risks are disclosed.
5Key risks mentioned include regulatory impacts (ACA, Medicare/Medicaid), healthcare cost trends, and competitive pressures.
6Significant legal risks related to ongoing litigation with Cigna are highlighted.
7Operational risks such as data security, IT systems, and PBM agreements (Express Scripts) are also noted.

Elevance Health, Inc. 8-K Report, Financial Results (Oct 31, 2018)

Summary

Key Highlights

Frequently Asked Questions